Morgan Stanley’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-1
Closed -$47 – 8317
2025
Q4
$47 Sell
1
-1
-50% -$37 ﹤0.01% 7875
2025
Q3
$85 Hold
2
– – ﹤0.01% 7713
2025
Q2
$79 Hold
2
– – ﹤0.01% 7682
2025
Q1
$79 Buy
2
+1
+100% +$39 ﹤0.01% 7613
2024
Q4
$45 Hold
1
– – ﹤0.01% 7644
2024
Q3
$57 Hold
1
– – ﹤0.01% 7541
2024
Q2
$58 Buy
+1
New +$35 ﹤0.01% 7453
2022
Q3
– Sell
-2,000
Closed -$60K – 7709
2022
Q2
$60K Hold
2,000
– – ﹤0.01% 6525
2022
Q1
$76K Hold
2,000
– – ﹤0.01% 6480
2021
Q4
$77K Hold
2,000
– – ﹤0.01% 6579
2021
Q3
$69K Hold
2,000
– – ﹤0.01% 6564
2021
Q2
$67K Hold
2,000
– – ﹤0.01% 6534
2021
Q1
$66K Hold
2,000
– – ﹤0.01% 6215
2020
Q4
$63K Hold
2,000
– – ﹤0.01% 6079
2020
Q3
$47K Hold
2,000
– – ﹤0.01% 5742
2020
Q2
$44K Hold
2,000
– – ﹤0.01% 5720
2020
Q1
$37K Hold
2,000
– – ﹤0.01% 5569
2019
Q4
$42K Hold
2,000
– – ﹤0.01% 5903
2019
Q3
$39K Buy
+2,000
New +$41.8K ﹤0.01% 5813

Other funds holding BOUT

Morgan Stanley's BOUT Position: Q1 2026 in Review

Morgan Stanley sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q1 2026, closing a stake of 1 share — an estimated $47 sold.

Morgan Stanley first reported a position in BOUT in Q3 2019 and held it in 19 quarters. The position peaked at $77K in Q4 2021. 14 funds tracked by Wall St. Rank hold BOUT as of Q1 2026.

  • Morgan Stanley reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q1 2026 after selling out during the quarter.
  • Morgan Stanley sold 1 CapForce IBD Breakout Opportunities ETF share in Q1 2026, an estimated $47.
  • Morgan Stanley first reported a position in CapForce IBD Breakout Opportunities ETF in Q3 2019 and held it in 19 quarters.
  • Morgan Stanley's CapForce IBD Breakout Opportunities ETF position peaked at $77K in Q4 2021.
  • 14 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.